COMMUNIQUÉS West-GlobeNewswire

Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026
Free platform empowers patients and families with information on 53 diseases, 125 genes, active clinical trials, treatment pipelines, and support resources GILBERT, Ariz., July 08, 2026 (GLOBE NEWSWIRE) -- Today, as co- [...]
Angelini Ventures Invests in Handspring Health's $19 Million Series B to Expand Access to High-Quality Mental Health Care for Children and Families
08/07/2026
Funding will support nationwide expansion of Handspring's clinician-led, evidence-based care model and technology platform for pediatric mental health care Angelini Ventures’ Sarah Fox joins Handspring's Board as an [...]
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
08/07/2026
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
08/07/2026
July 16 in Boston, management will engage with investors and industry participants at the healthcare-focused event covering neuropsychiatry, neurodegeneration, neuromuscular disease, ophthalmology, and neuroimmunology [...]
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
08/07/2026
Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine platform designed to [...]
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
08/07/2026
Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions, will be appointed as Chief Business Officer Charles Carter promoted to Chief Financial Officer, reflecting his strong [...]
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
08/07/2026
Novo Nordisk s’apprête à mener une évaluation interne non exclusive des implants à base de sémaglutide élaborés par Vivani ALAMEDA, Californie, 08 juill. 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq : VANI) (« [...]
On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper
08/07/2026
SHENZHEN, China, July 08, 2026 (GLOBE NEWSWIRE) -- WONDERLAB, a leading Chinese probiotics company ranked No.1 in probiotic sales in China,¹ has published the Targeted Microbiota Weight Management White Paper, a strain- [...]
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
08/07/2026
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as Tensive approaches pivotal clinical and regulatory milestones for its [...]
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
08/07/2026
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer. Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake [...]
Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk
08/07/2026
Trimoryn issues a 2026 supplement facts and consumer safety update covering its weight management support formula, ingredient amounts, suggested use, side effects risk considerations, customer support details, and 60- [...]
AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins
08/07/2026
NEURIED, Germany and NESLE, France, July 08, 2026 (GLOBE NEWSWIRE) -- AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe ( [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08/07/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08/07/2026
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08/07/2026
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics [...]
Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving Equipment
07/07/2026
Every FLYTE aircraft combines the Cirrus Vision Jet’s CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment . Partnership reflects FLYTE’s safety-first philosophy, [...]
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2026
07/07/2026
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2026 La dynamique soutenue du lancement aux États-Unis porte le chiffre d'affaires net préliminaire mondial du deuxième trimestre à 7,7 millions d' [...]
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
07/07/2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net revenue of €7.7 million CMS proposes 2027 OPPS and ASC payment increase of [...]

Pages